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The steady-state brain is associated with im-
mune privilege, i.e., a paucity of lymphocytes 
and an inability to initiate immunity. The latter 
has been attributed, at least in part, to a lack   
of DCs (Bailey et al., 2006). Central nervous 
system (CNS) infiltration of leukocytes has been 
largely perceived as a feature of neuroinflam-
mation in which there is a break in the blood 
brain barrier (Hickey, 1991; Platten and Steinman, 
2005; Bailey et al., 2007).
In spite of immune privilege, an immune 
contribution to hippocampal neurogenesis was 
first  proposed  based  on  the  observation  that   
T cell loss is associated with dementia arising in 
both HIV patients and recipients of immuno-
suppressive chemotherapy (Price et al., 1988; 
Hess  and  Insel,  2007).  Improved  cognitive 
function occurs during reconstitution of T cell 
immunity in both humans and mice (Ziv et al., 
2006; Kipnis et al., 2008; Wolf et al., 2009). 
Recent studies demonstrate that in the healthy 
CNS, memory and cognition are CD4+ T cell 
dependent. In particular, IL-4–producing T cells 
accumulate  in  the  meningeal  space  during 
cognitive tasks (Derecki et al., 2010). That 
learning is impaired in the absence of CD4+  
T cell cytokine production links, for the first 
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Antigen-presenting cells in the disease-free brain have been identified primarily by expres-
sion of antigens such as CD11b, CD11c, and MHC II, which can be shared by dendritic cells 
(DCs), microglia, and monocytes. In this study, starting with the criterion of Flt3 (FMS-like 
receptor tyrosine kinase 3)-dependent development, we characterize the features of  
authentic DCs within the meninges and choroid plexus in healthy mouse brains. Analyses of 
morphology, gene expression, and antigen-presenting function established a close relation-
ship between meningeal and choroid plexus DCs (m/chDCs) and spleen DCs. DCs in both 
sites shared an intrinsic requirement for Flt3 ligand. Microarrays revealed differences in 
expression of transcripts encoding surface molecules, transcription factors, pattern recog-
nition receptors, and other genes in m/chDCs compared with monocytes and microglia. 
Migrating pre-DC progenitors from bone marrow gave rise to m/chDCs that had a 5–7-d 
half-life. In contrast to microglia, DCs actively present self-antigens and stimulate T cells. 
Therefore, the meninges and choroid plexus of a steady-state brain contain DCs that derive 
from local precursors and exhibit a differentiation and antigen-presenting program similar 
to spleen DCs and distinct from microglia.
© 2011 Anandasabapathy et al.  This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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as  the  expression  is  also  found  on  monocytes,  plasma-
cytoid DCs, activated lymphocytes, and activated microglia   
(Geissmann et al., 2003; Gottfried-Blackmore et al., 2009). 
CD11b,  commonly  used  as  the  macrophage  marker,  also 
lacks lineage specificity and is expressed by macrophages, 
monocytes, microglia, and some DC subsets (Geissmann et al., 
2010). In this study, to better identify and understand APCs 
in the steady-state brain, we used developmental criteria, 
transcriptional profiling, and function and used these compo-
nents of cell function to distinguish DCs from monocytes, 
macrophages, and microglia.
RESULTS
Flt3L selectively expands CD11c and MHC II–high 
leukocytes in the disease-free mouse brain
To identify DCs in the steady-state brain, we phenotyped 
CD45+  leukocytes  in  cell  suspensions,  comparing  normal 
mice with those treated with Flt3L, a potent DC hemato-
poietin. Based on the responsiveness of the DC lineage to Flt3L 
in many tissues, we reasoned that this hematopoietin might 
expand and better define populations of brain DCs. Addition-
ally, we revisited previously described CD11c–enhanced YFP 
(EYFP) reporter mice to detect EYFP-high DCs with a char-
acteristic morphology (Lindquist et al., 2004; Choi et al., 
2009). In naive CD11c-EYFP mice, flow cytometry analysis 
for  EYFP  and  CD45  expression  (to  identify  leukocytes) 
showed EYFP+ cells in both CD45int and CD45hi popula-
tions, but 14 d after Flt3L treatment, only the CD45hiEYFP+ 
cells expanded and expressed high cell surface CD11c and 
MHC II (Fig. 1 A). In contrast, CD45intEYFP+ and EYFP 
cells did not expand with Flt3L treatment. The nonresponsive 
CD45intEYFP+ cells were CD11c and MHC II negative in 
contrast to the responsive CD45hiEYFP+CD11c+MHC II+ 
cells (Fig. 1 A). Interestingly, CD11c-EYFP mouse spleen also 
contains two populations of EYFP+ cells. One population with 
a CD11c+MHC II+ cDC phenotype expanded in response to 
Flt3L injection. In contrast, the other CD11clo population, the 
majority of which displayed a CD11bloF4/80hi red-pulp macro-
phage phenotype, did not respond to Flt3L injection (Fig. 1 B). 
Thus, we conclude that CD11c-EYFP mouse spleen and brain 
contain two populations of EYFP+ cells that are developmentally 
distinct based on their Flt3L responsiveness.
In the brains of nontransgenic C57BL/6 (B6) mice, i.e.,   
without the use of the CD11c-EYFP reporter, a population of 
LinCD45hiCD11chiMHC IIhi cells was detected, and these were 
the cells that expanded more than fivefold after Flt3L treat-
ment (Fig. 1, C and D). In contrast, LinCD45intCD11c cells, 
presumably microglia, did not show significant responses to Flt3L 
treatment (Fig. 1, C and D). These data with Flt3L responsiveness 
and CD11c/MHC II expression strongly imply the presence of 
cells in the brain that are similar to DCs in other organs.
Flt3L-responsive DCs localize to the meninges  
and choroid plexus
To  localize  these  populations  in  naive  and  Flt3L-treated 
mice, we examined brains from CD11c-EYFP transgenic 
time, immune activity to steady-state cognitive function. The 
meninges and the choroid plexus were also recently demon-
strated to be the site or gateway for entry of activated   
effector T cells into the CNS (Axtell and Steinman, 2009;   
Bartholomäus et al., 2009; Reboldi et al., 2009). These find-
ings leave a major gap: what is the nature of the APCs that 
guide T cell function?
DCs are specialized APCs that mediate systemic T cell 
tolerance and immunity (Banchereau and Steinman, 1998; 
Heath and Carbone, 2009). In the steady-state, most DCs 
originate from a common DC precursor called pre-DCs   
(Liu et al., 2009). Pre-DCs arise from committed DC pro-
genitors in the bone marrow, migrate through the blood, and 
seed lymphoid and nonlymphoid tissues, where they undergo 
a limited number of divisions and differentiate into special-
ized DC subsets (Liu et al., 2009). DC development is depen-
dent on Flt3 (FMS-like receptor tyrosine kinase 3) ligand 
(Flt3L), a hematopoietin acting primarily on DCs and their 
progenitors that express Flt3/CD135 receptor, both in the 
bone marrow and the periphery (Waskow et al., 2008; Kingston 
et al., 2009).
Resident DCs have been defined in nonlymphoid organs 
including the skin, lung, gut, and kidney (Bogunovic et al., 
2009; Ginhoux et al., 2009; Rescigno and Di Sabatino, 2009; 
Varol et al., 2009; Henri et al., 2010), but there is little charac-
terization of DCs in the steady-state brain. The choroid plexus 
and meninges were identified as the gates of entry for acti-
vated T cells into the brain by a mechanism involving the 
chemokine receptor CCR6 (Kivisäkk et al., 2003; McMenamin 
et  al.,  2003;  Bartholomäus  et  al.,  2009;  Reboldi  et  al.,   
2009). Cell surface staining with individual markers MHC II, 
CD11c, CD11b, OX62, and DEC205 suggested the presence 
of APCs in the choroid plexus and meninges, and functional 
study of targeted MHC II expression in CD11c+ cells attri-
buted the onset of neuroinflammation to an increase of APCs 
in these gateways (Matyszak and Perry, 1996; McMenamin, 
1999; Greter et al., 2005; Serafini et al., 2006; Kivisäkk et al., 
2009). However, a precise characterization of these APCs in 
the steady-state is lacking because of their limited numbers, a 
lack  of  imaging  tools,  and  the  absence  of  lineage-specific 
markers. Also, as discussed extensively elsewhere (Geissmann 
et al., 2010), the aforementioned markers MHC II, CD11c, 
CD11b, and DEC205 lack specificity and as such fail to dif-
ferentiate among multiple lineages. Identification of the DC 
lineage requires information on location, development, tran-
scriptional programs, and function.
High levels of CD11c, for instance, was initially identi-
fied as a useful marker to identify DCs, and the CD11c pro-
moter was used to generate genetically modified mice to 
study DC distribution and function. Indeed, studies with 
CD11c-DTR and CD11c-DT as well as CD11c-MHC II 
mice demonstrated that DCs could both prime T cells and 
maintain T cell tolerance, but these studies include comple-
mentary experiments with isolated DCs, typically from lym-
phoid tissues (Jung et al., 2002; Lemos et al., 2003). However, 
CD11c is not restricted to conventional DC (cDC) lineage JEM Vol. 208, No. 8 
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flow cytometric analysis showed that most   
meningeal  and  splenic  EYFP+  cells  were 
CD11c+MHC II+; in contrast, the majority 
of EYFP+ cells in brain parenchyma displayed 
a microglia phenotype, i.e., CD45intCD11c 
MHC II (Fig. S1). In line with the data 
from CD11c-EYFP reporter mice, we ob-
served  an  enrichment  of  CD11c+CD45hi 
DCs in the meninx preparations from naive 
B6 WT animals (7.5% ± 0.35%) when com-
pared with whole brain preparations (3 ± 
0.66%)  of  untreated  mice  (Fig.  2  D).  A 
marked  enrichment  in  DC  numbers  was 
quantified by flow cytometry in the menin-
geal preparation and in whole brain preps after Flt3L treat-
ment, whereas microglia numbers remained unchanged in 
whole brain (Fig. 2 D, graph). We also examined the meninges 
from CX3CR1gfp/+ mice. In contrast to microglia that were 
mostly CX3CR1-GFP+ (95%), meningeal DCs and spleen 
DCs were heterogeneous in CX3CR1-GFP (Fig. S2 A), and 
both CX3CR1-GFP+ and CX3CR1-GFP DCs were ex-
panded by Flt3L (Fig. S2 B).
For  further  confirmation,  we  examined  I-Ab–EGFP 
knockin mice, in which cellular MHC II levels correlate 
with EGFP signal (Boes et al., 2002). En face two-photon 
imaging revealed numerous EGFP+ cells with classical DC 
morphology in the upper 30 µm of the brain, corresponding 
to the dura mater and pia mater of the meninges. In contrast, 
no EGFP+ cells were detected deeper in the tissue (35–90 µm), 
which correlated with the parenchyma immediately below 
the meninges (Fig. 2 E and Video 1). Coronal sectioning 
likewise revealed EGFP+ cells with DC morphology in   
the  choroid  plexus  but  not  in  the  parenchyma  in  the 
steady-state (Fig. 2 E). Flow cytometry confirmed that all 
LinCD45hiCD11c+ but none of the LinCD45intCD11c 
brain  leukocytes  in  these  mice  were  EGFP+  (Fig.  2  E). 
Therefore, the data from I-Ab–EGFP mice again indicate the 
mice  with  two-photon  microscopy. We  detected  EYFP+ 
cells along the meninges, in the choroid plexus, and in the 
parenchyma of coronal sections (Fig. 2 A). We then labeled 
blood  vessels  with  DiI  dye  and  imaged  the  intact  brain   
en face, from the top downward. DiI labeled major blood ves-
sels in the dura mater (Fig. 2 B, top) as well as capillary blood 
vessels in the pia mater (Fig. 2 B, bottom), marking the ana-
tomical layers of the meninges. Some but not all EYFP+ 
cells  with  thick  dendrites  were  located  near  meningeal 
blood vessels (Fig. 2 B). After Flt3L treatment, a dramatic 
expansion of EYFP+ cells was observed in discrete patches 
along the meninges, but in contrast, no significant change 
in the quantity of parenchymal EYFP+ cells was observed 
(Fig. 2 C). EYFP+ cells in the meninges and choroid plexus 
displayed a distinct morphology, with large cell bodies and 
several thick dendrites per cell, which is consistent with that 
of typical DCs. In contrast, parenchymal EYFP+ cells were 
highly ramified and displayed a phenotype typical of mi-
croglia (Fig. 2 A, bottom).
Next, we compared bulk meninges and parenchyma to 
meningeal isolates in the presence and absence of Flt3L   
treatment. Consistent with the localization of EYFP+ cells   
in the meninges of CD11c reporter mice by microscopy, 
Figure 1.  Phenotype of Flt3L-responsive 
CD45hiCD11c+MHC II+ cells in the steady-state 
mouse brain. (A and B) Flow cytometric dot plots  
of EYFP expression in brain leukocytes (A) and the spleno-
cytes (B) of untreated (top) versus Flt3L-treated  
(bottom) CD11c-EYFP transgenic mice. Numbers indi-
cate percentage of gated cells. Data are representa-
tive of three independent experiments. (C) Flow 
cytometric dot plots of CD45+ mononuclear cells in 
the brain of untreated (top) versus Flt3L-treated (bot-
tom) nontransgenic C57BL/6 mice. Histograms show 
MHC II staining on the surface of DCs and microglia 
(MG) from the indicated gates. Data are representa-
tive of more than three independent experiments.  
(D) Bar graph shows quantification of m/chDCs and 
microglia 14 d after Flt3L treatment in B6 mice. Bars 
represent data from two pooled experiments, each 
with two brains. Error bars represent the mean ± SEM 
(n = 4; ***, P < 0.0001).1698 DCs in the steady-state mouse brain | Anandasabapathy et al.
cells with typical DC morphology, and they are located in 
the meninges and choroid plexus. We will refer to CD45/
CD11c/MHC IIhi cells in the brain as meningeal and cho-
roid plexus DCs (m/chDCs), as opposed to microglia, which 
are LinCD45intCD11c/loMHC II.
presence of MHC II+ cells with DC morphology in the   
meninges and choroids plexus but not in the parenchyma of 
the mouse brain.
These observations show that the LinCD45hiCD11c+ 
MHC II+ brain cells correspond to Flt3L-responsive EYFP 
Figure 2.  Flt3L-responsive cells with dendritic morphology within meninges and choroid plexus. (A) Two-photon microscopy showing fluores-
cent cells in coronal brain sections of untreated CD11c-EYFP mice. EYFP+ cells were detected in choroid plexus (C.P.) and parenchyma (top left) and menin-
ges and parenchyma (top right). Small panels at the bottom show the morphology of individual EYFP+ cells from choroid plexus, meninges (en face view), 
and parenchyma. (B) En face two-photon view of the brains of untreated CD11c-EYFP mouse brains. Blood vessels (red) were labeled by perfusion with DiI. 
EYFP+ (green) cells were detected in the meninges. Panels show a major blood vessel in the dura mater (top) and capillary blood vessels in the pia mater 
(bottom). (C) Two-photon microscopy coronal sections from the brain of untreated (top) and Flt3L-treated (bottom) CD11c-EYFP mice (green, EYFP).  
(D) Flow cytometric analysis of DCs in meningeal isolates. Dot plots show gated CD45hiCD11chi DCs in CD45+ leukocytes of meningeal isolates and whole brain 
preparation in untreated or Flt3-treated B6 mice. Numbers indicate percentage of each cell type within total CD45+ cells. Bar graphs summarize the per-
centage of m/chDCs and microglia (MG) among CD45+ brain leukocytes in untreated versus Flt3L-treated mice in bulk brain and meninges (gating shown  
in Fig. S1 B). Bars show data from one representative experiment (n = 5 mice per group). Error bars represent the mean ± SD (n = 5). (E) Two-photon micros-
copy and flow cytometry of EGFP+ cells in the brain of I-Ab–EGFP transgenic mice. (microscopy) Observation in meninges 0–30 µm (left) and parenchyma 
35–90 µm (middle) from the upper limit of the brain and in choroid plexus (right) from coronal sections of untreated I-Ab–EGFP mice (yellow, EGFP;  
red, collagen fiber; white, autofluorescence). Flow cytometry histograms show overlay of EGFP expression on microglia and m/chDCs, gated as in Fig. 1 B, 
from WT B6 (shaded area) and I-Ab–EGFP (line) mice. Data are representative of two independent experiments. Bars: (A, C, and E) 50 µm; (B) 100 µm.JEM Vol. 208, No. 8 
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et  al.,  2007). We  conclude  that  brain   
m/chDCs,  in  contrast  to  microglia,  are 
radiosensitive and that their development 
is dependent on Flt3 signaling.
m/chDCs and CD8+ spleen DCs share gene  
expression profiles
To further understand the functional relationship between 
m/chDCs and other myeloid cells, we compared the gene 
expression profile of m/chDCs with that of bone marrow 
monocytes, brain microglia, and classical spleen CD8+ and 
CD8 DCs. To obtain enough m/chDCs for messenger RNA 
(mRNA) extraction, we expanded m/chDCs with in vivo 
Flt3L treatment before purification. Consistent with a pre-
vious  study  showing  that  Flt3L  stimulates  DC  expansion 
without maturing them (Dudziak et al., 2007), we found no 
change  in  maturation  markers  CD80,  CD86,  CD40,  and 
MHC II (I-A) in Flt3L-treated m/chDCs (Fig. S3). With re-
spect to growth factor receptors, m/chDCs expressed high 
levels of Flt3 and low levels of MCSF-R mRNA, which is 
similar to spleen DCs. In contrast, monocytes and microglia 
did not express Flt3 signal but did express high amounts of 
MCSF-R. GMCSF-R message was expressed by all cell pop-
ulations, with higher levels noted in m/chDCs and CD8+ 
spleen DCs (Fig. 4 A).
Looking further, we found that m/chDCs shared mRNA 
expression of many cell surface molecules with CD8+ spleen 
DCs, including high CD103, CD24a, and CD36. They also 
expressed CD207 and CD205 mRNAs but at lower levels 
than CD8+ DCs (Fig. 4 B). m/chDCs had high TLR3 and 
low TLR4 signals. TLR3 is a typical pattern recognition re-
ceptor  on  CD8+  spleen  DCs,  whereas  monocytes  express 
high TLR4 and no TLR3 (Fig. 4 C). Similar to spleen DCs, 
m/chDCs express Flt3 and have an intrinsic requirement  
for Flt3 signaling
To understand the development of m/chDCs, we pursued 
findings that classical DCs in lymphoid and other nonlym-
phoid organs, such as liver, gut, kidney, and lung, express Flt3 
(or Flk2) and that their development critically depends on 
Flt3 signaling (Bogunovic et al., 2009; Ginhoux et al., 2009). 
Similar to spleen DCs, m/chDCs expressed cell surface Flt3/
CD135 but not M-CSFR/CD115, whereas microglia were   
Flt3 negative and M-CSFR positive (Fig. 3 A). Likewise, in Flt3L   
KO mice, we observed an 80% decrease in the number of   
m/chDCs, whereas microglia developed normally (Fig. 3 B).
To determine whether the requirement for Flt3 signaling 
was intrinsic to m/chDCs, we made mixed bone marrow   
chimeras in which 50:50 mixtures of marrow from Flt3+/+ 
CD45.2 and Flt3/ CD45.1 mice were injected into lethally 
irradiated CD45.1 × CD45.2 F1 recipients. Because neutro-
phil development is independent of Flt3, their representation 
from each donor was used to follow the input ratio of hema-
topoietic stem cells in each mouse. As a positive control, we 
found that Flt3/ spleen DCs were outcompeted by Flt3+/+ 
DCs, whereas splenic monocytes, which are Flt3 indepen-
dent, arose from Flt3+/+ and Flt3/ stem cells in ratios equal 
to the neutrophil ratios (Fig. 3 C). Brain m/chDC develop-
ment was similar to that of spleen DCs, demonstrating an   
intrinsic requirement for Flt3 signaling (Fig. 3 C). However, 
microglia were largely radio resistant and retained the host 
phenotype (Fig. 3 C), as expected from prior research (Mildner   
Figure 3.  m/chDCs express Flt3 and have an 
intrinsic dependence on Flt3L. (A) Histograms 
show cell surface expression of Flt3 receptor and 
M-CSF receptor (CD115; line) or isotype anti-
body control (shaded area) on gated microglia 
and m/chDCs in the brain versus CD8 and CD8+ 
DC subsets in the spleen (Sp). (B) Bar graph shows 
percentage of m/chDCs and microglia among 
CD45+ brain leukocytes in WT versus Flt3L KO 
mice. Bars represent data from two pooled ex-
periments (n = 4). Error bars represent the  
mean ± SEM (n = 4). (C) Lethally irradiated 
CD45.1+CD45.2+ F1 recipient mice were reconsti-
tuted with a mixture of 50% CD45.1+ Flt3 KO and 
50% CD45.2+ WT bone marrow and analyzed 2–3 
mo later. Bar graph shows the percentage of indi-
cated cells from Flt3 KO CD45.1+ (open) and WT 
CD45.2+ (red) donor or CD45.1+CD45.2+ recipient 
(blue) origin. Bars represent data from three ani-
mals. Error bars represent the mean ± SEM (n = 3; 
*, P < 0.05; **, P < 0.01). Dot plots show percent-
age of donor and recipient cells in gated cell pop-
ulations analyzed by flow cytometry, representing 
two independent experiments.1700 DCs in the steady-state mouse brain | Anandasabapathy et al.
with CD11b, CD24, CD36, CD103, Dectin, EpCam, and 
CD205 confirmed the resemblance between m/chDCs and 
spleen DCs in untreated mice and the distinction from   
microglia (Fig. S4).
With respect to some other products, we noted that both 
spleen  CD8+  DCs  and  m/chDCs  expressed  high  IL-12 
mRNA, although IL-12 was not found (Fig. 4 D and not 
depicted). For transcription factors that program DC differen-
tiation, m/chDCs demonstrated high expression of mRNAs 
for transcription factors Batf3, Id2, and RBP-J, each known 
to be involved in the differentiation of CD8+ DCs in spleen 
(Fig. 4 E; Hacker et al., 2003; Caton et al., 2007; Hildner et al., 
2008), suggesting a similar molecular programming during 
the development of m/chDCs and spleen DCs. Transcription 
factors differentially expressed in m/chDCs and spleen CD8+ 
DCs include IRF-4, a transcription factor essential for CD4+ 
splenic DC development (Fig. 4 E; Suzuki et al., 2004), sug-
gesting tissue-specific differentiation programming. In sum-
mary, the gene expression profiles of m/chDCs suggest a close 
relationship with CD8+ spleen DCs.
m/chDCs originate from a pre-DC marrow precursor  
and have a half-life of 5–7 d
To ascertain the origin of m/chDCs, we took advantage of 
our recent findings that the progenitors of lymphoid organ 
DCs and monocytes split during the transition between the 
monocyte and DC progenitor (MDP) and common DC 
progenitor (CDP) stages of development in the bone mar-
row (Fogg et al., 2006; Naik et al., 2007; Onai et al., 2007; 
Liu et al., 2009). Whereas MDPs give rise to monocytes and 
CDPs, the latter are restricted to produce DCs via migrating 
pre-DC intermediates. To examine whether DC precursors 
give rise to m/chDCs, we first adoptively transferred Flt3+ 
BM DC precursors from CD11c-EYFP mice i.v. into non-
irradiated naive mice. To examine the Flt3L responsiveness, 
we used Flt3/ mice as recipient; thus, only donor cells 
could expand by Flt3L injection. 7 d after transfer, imaging 
of whole-mount brain indicated that donor-derived cells 
from EYFP+ donor were only found in meninges but not 
parenchyma (Fig. S5). Furthermore, the donor cells were 
expanded by Flt3L injection (Fig. S5). To further investigate 
the exact precursor of the m/chDCs, we purified MDPs, 
CDPs, pre-DCs, and monocytes to >95% purity from the 
bone marrow and adoptively transferred them into the 
femurs of allotype-marked naive 3–4-wk-old mice. When 
we examined m/chDCs 1 wk later with flow cytometry, we 
found donor-derived brain DCs from mice that received   
1–1.5 × 105 MDPs, CDPs, and pre-DCs (Fig. 5 A). In contrast, 
we did not detect any m/chDCs from mice that received 
30–50 times more monocytes (5 × 106; Fig. 5 A). We rea-
soned that pre-DCs migrate to the brain meninges and cho-
roids plexus where they further differentiate into cDCs, as 
we previously demonstrated in the spleen and lymph node 
(Liu et al., 2009). Indeed, a population of pre-DCs was de-
tected in the brain leukocyte fraction and further enriched 
in meningeal preparation (0.3–0.4% of CD45+ cells, which 
m/chDCs  expressed  high  H2-DMb,  H2-Aa,  and  H2-Ab, 
which are molecules critical for antigen presentation to CD4+ 
T cells, but these were not expressed by monocytes or mi-
croglia. m/chDCs expressed intermediate levels of CD40 and 
CD80. To evaluate how the array data from Flt3L-expanded 
m/chDCs reflected those from the naive mice, we examined 
some of the cell surface markers in the naive mice with flow 
cytometry. Indeed, besides the aforementioned lineage markers 
CX3CR1 (Fig. S2), Flt3, and CD115 (Fig. 3 A), phenotyping 
Figure 4.  Gene expression profiles of m/chDC versus microglia, 
monocytes, and spleen DCs. Bone marrow monocytes, spleen (Spl) CD8+ 
and CD8 DC subsets from untreated B6 mice and brain m/chDCs, and 
microglia from B6 mice treated with Flt3L were purified, and mRNA was 
extracted for Affymetrix gene array analysis. (A–E) Graphs show normal-
ized data comparison among the indicated cells for expression of recep-
tors for growth factors (A), cell surface markers (B), pattern recognition 
molecules (C), antigen presentation and co-stimulatory molecules (D), and 
transcription factors (E). Error bars indicate mean ± SEM (n = 3).JEM Vol. 208, No. 8 
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spleen DCs (Fig. 5 D). We conclude that m/chDCs originate 
from pre-DCs and the DC developmental pathway in the 
bone marrow, and not from monocytes, and that they have a 
life span of 1–2 wk.
m/chDCs are effective in antigen presentation  
and stimulation of T cells
To examine antigen presentation in situ, the formation of 
peptide–MHC complexes by m/chDCs, we first stained cells 
with  antibodies to  the complex  of I-E  peptide on  I-Ab 
MHC  II  molecules  (Y-Ae;  Rudensky  et  al.,  1991).  Both 
spleen DCs and m/chDCs from BALB/c × B6 (CB1) mice 
stained positive for Y-Ae, whereas DCs from either BALB/c 
or C57BL/6 (B6) did not, indicating that DCs process and 
present an endogenous I-E peptide onto I-Ab MHC II mol-
ecules (Fig. 6 A). In contrast, we did not detect this peptide–
MHC complex on microglia from CB1 mice.
To evaluate the capacity of m/chDCs   
to initiate an immune response, we 
tested their ability to stimulate allo-
geneic T cells. Purified m/chDCs were 
compared  with  microglia  and  spleen 
DCs  from  Flt3L-injected  B6  mice   
(H-2b) by co-culture with CFSE-labeled 
bulk T cells (H-2d) from BALB/c mice. 
is 10-fold higher than that of pre-DCs in blood; Fig. 5 B and 
Fig. S6). Similar to pre-DCs in spleen and blood, the brain 
pre-DCs were CX3CR1-GFP+ and expanded in situ in re-
sponse to Flt3L injection (Fig. S6 C). Consistent with these 
adoptive transfer experiments, the exchange of m/chDCs in 
parabiotic mice was similar to blood pre-DCs and spleen 
DCs (Fig. 5 C), supporting a continuous equilibrium of   
m/chDCs with pre-DCs in the blood.
To measure the life span of m/chDCs, we tracked the   
decay of m/chDC chimerism in separated parabionts as we 
previously established (Liu et al., 2007; Ginhoux et al., 2009). 
Parabionts were established between CD45.1 and CD45.2 
mice, and leukocytes were allowed to equilibrate in the tis-
sues for >35 d before separation. In time course experiments, 
parabiont-derived m/chDCs showed a 50% decrease between 
5 and 7 d and totally disappeared by day 14. Thus, m/chDCs 
have a half-life of 5–7 d, which is a similar life span to that of the 
Figure 5.  Origin and differentiation of 
brain m/chDCs. (A) The indicated numbers  
of purified MDPs, CDPs, pre-DCs, and mono-
cytes from bone marrow of CD45.1+CD45.2+ 
mice were transferred into naive CD45.2+  
congenic hosts. Dot plots show the phenotype 
of m/chDCs, and the numbers indicate percent-
ages derived from the donor 7 d after transfer.  
(B) Dot plots show percentages of 
CD45+LinCD11c+MHC IIFlt3+SIRPlo pre-DCs 
among bulk brain and meningeal leukocytes. 
Numbers in the parentheses represent the 
mean pre-DC percentage of CD45+ leukocytes 
(red arrows, pre-DCs). Histograms show GFP 
expression of gated pre-DCs in CX3CR1gfp (line) 
versus WT (shaded) mice. (C) CD45.1 and 
CD45.2 mice were surgically joined for 60 d. 
Graph shows the percentage of partner- 
derived T cells, blood pre-DCs, spleen DCs, brain 
m/chDCs, and microglia. Dot plots show repre-
sentative percentages of CD45.1 and CD45.2 
cells among m/chDCs and microglia in CD45.1 
and CD45.2 parabionts. The bar graph shows 
two independent experiments with more  
than three mice in total. (D) CD45.2 and  
CD45.1 B6 mice were surgically joined for  
60 d together before being separated. Graphs 
show the percentage of parabiont-derived DCs 
among each DC subset in the spleen and brain 
at different time points after separation. Bars 
represent two separate parabionts at each time 
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transgenic T cells were used (Bettelli et al., 2003). Although 
the steady-state spleen DCs and m/chDCs did not present 
self-MOG antigen, they induced vigorous T cell proliferation 
when MOG peptide was added to the APC:T cell cultures, 
whereas microglia were inactive (Fig. 6 C). Therefore, although   
it has been reported that m/chDCs present self-antigen and 
stimulate T cell proliferation during the onset of neuroinflam-
mation (Kivisäkk et al., 2009), in the steady-state, we did not   
observe priming of autoreactive T cells.
DISCUSSION
In this study, we demonstrate that CD45hiCD11chiMHC IIhi 
cells in the meninges and choroid plexus of the steady-state 
mouse brain are typical DCs based on functional and devel-
opmental criteria. Our experiments on m/chDCs emphasize 
their resemblance to classical Flt3L-dependent DCs (cDCs) 
in spleen as well as major differences from microglia.
The entry of T cells into the parenchymal space is pre-
ceded by interaction with APCs in the leptomeningeal mem-
brane, yet the nature and origin of these APCs were unclear. 
Using  developmental  and  functional  criteria,  we  observe 
CD11c and MHC II high stellate cells within the meninges 
and choroid plexus (m/chDCs) of naive mice and that these 
are authentic DCs in the steady-state brain positioned to meet 
and greet T cells along the avenues of effector T cell entry 
(Kivisäkk et al., 2003) and at the sites of IL-4 T cell recruit-
ment during learning (Derecki et al., 2010). Although the   
m/chDCs are equipped with antigen-presenting machinery 
to interact with T cells, we did not observe T cell responses to 
autoreactive self-antigens in the healthy brain (Fig. 6 C). Yet 
when the balance is broken by neuroinflammation and self-
antigen becomes readily available, these cells likely are able to 
present antigen to MOG-reactive T cells and accelerate the 
onset of disease (Kivisäkk et al., 2009; Wu et al., 2011). This is 
consistent with a previous study showing that Flt3L exacer-
bates disease severity in the experimental autoimmune en-
cephalomyelitis model (Greter et al., 2005). Besides antigen 
presentation capacity, m/chDCs differ from parenchymal mi-
croglia in ontogeny. Ginhoux et al. (2010) demonstrated that 
the adult microglia arise from primitive myeloid progenitors 
before embryonic day 8 and do not need postnatal replenish-
ment from blood. In contrast, like most cDCs in lymphoid 
tissues, m/chDCs have a 5–7-d half-life and as such are con-
stantly replenished from bone marrow pre-DCs distinct from 
monocytes in an Flt3L-dependent manner. Our transcrip-
tional profiling analysis further relates the m/chDCs to cDCs 
in spleen based on expression of transcription factors, includ-
ing Batf3, RBP-J, and Id2, that are required for DC develop-
ment.  Functional  analysis  of  purified  m/chDCs  indicates   
high surface levels of endogenous peptide–MHC complexes 
formed in situ, and when isolated they can actively stimu-
late alloreactive and MOG-reactive T cells in vitro. In all re-
spects, m/chDCs differ from microglia, which are abundant in   
brain parenchyma.
Collectively, the unique anatomical distribution and anti-
gen presentation features of m/chDCs support their role as an 
The m/chDCs and spleen DCs induced vigorous and compa-
rable T cell proliferation, whereas microglia did not (Fig. 6 B).
To evaluate presentation of a self-antigen, myelin oligo-
dendroglial glycoprotein (MOG) and MOG reactive, TCR 
Figure 6.  Antigen presentation by m/chDCs. (A) Flow cytometry histo-
grams show Y-Ae antibody (line) or isotype (shaded area) staining of gated 
spleen DCs, brain m/chDCs, and microglia from B6 or BALB/c × B6 (CB1) 
mice. (B) CFSE-labeled BALB/c T cells were incubated with spleen DCs, brain 
m/chDCs, or microglia (MG) isolated from B6 mice treated with Flt3L and 
were analyzed with flow cytometry 4 d later. Graph shows percentage of 
proliferated T cells among total CD3+ T cells, indicated by dilution of CFSE. 
One of three representative experiments is shown. (C) CFSE-labeled 2D2 
MOG-specific CD4+ transgenic T cells were incubated with spleen DCs, 
brain m/chDCs, or microglia isolated from B6 mice treated with Flt3L with 
the indicated doses of MOG peptide and were analyzed by flow cytometry 
4 d later. Graph shows percentage of proliferated (CFSElo) T cells among 
total CD3+ T cells. One of three representative experiments is shown.  
(B and C) Error bars show the SD between triplicate wells.JEM Vol. 208, No. 8 
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pieces and treated with 375 mU/ml collagenase (type II; Roche) with 
400 mg DNase in Hanks’ buffer for 45 min at 37°C, followed by homogeni-
zation with vigorous pipetting using glass pipettes. Homogenates were re-
incubated for 15 min at 37°C. 20 mM EDTA was added for 5 min at 37°C.   
All subsequent washes were performed with ice-cold PBS with 2% FCS. 
Brain homogenate was washed and filtered once through a 100-µM filter to 
remove undigested fragments and then washed twice again, followed by cen-
trifugation at 2,000 rpm for 10 min. Cells were resuspended in 40% Percoll 
under 5 ml PBS and centrifuged at 1,200 g for 25 min (slow accelerations 
and decelerations off) at 20°C in a J-20 rotor (Sorvall). Cells were harvested 
from the pellet, washed twice, and incubated in Fc block with 2% rat serum 
before cell surface marker antibody staining. Spleens and meninges were 
mixed in 5 ml Hanks’ buffer containing 375 mU/ml collagenase (type II), 
teased apart, and then incubated for 25 min at 37°C. For disruption of DC–T 
cell complexes, 10 mM EDTA was added, and mixing continued for the last 
5 min of incubation. For spleen cell preparation, ACK lysis of red blood cells 
was followed by washing twice and filtering undigested fibrous material 
through a 100-mm cell strainer. All subsequent steps were performed at 4°C 
with 5% (vol/vol) FBS in PBS. Undigested fibrous material was removed by 
filtration through a 100-mm cell strainer. All subsequent steps were per-
formed at 4°C with 5% (vol/vol) FBS in PBS.
For adoptive transfer experiments, MDPs, CDPs, and pre-cDCs were 
pre-enriched by biotin–anti-Flt3 antibody followed by antibiotin micro-
beads. Monocytes were pre-enriched by biotin–anti-CD115 antibody fol-
lowed  by  antibiotin  microbeads.  Positive  fractions  from  Miltenyi  Biotec 
columns were eluted and either directly used to transfer or stained and sorted 
on FACS Aria (BD) to >95% purity.
Antigen presentation assays. For the mixed leukocyte reaction, T cells 
were enriched by negative selection from BALB/c and B6 spleen and lymph 
nodes by grinding organs between two frosted glass slides into complete 
RPMI medium with 5% FCS. Cells were washed twice, followed by filtration 
of debris through a 70-µM filter, and then incubated in MACS buffer (2% 
FCS and 2 mM EDTA) with biotin-labeled CD11b, B220, DX5 (CD49b), 
Gr.1, MHC II (I-A/I-E), and Ter119 antibodies. Subsequent streptavidin 
bead incubation and negative enrichment were performed via the MACS 
(Miltenyi Biotec) LD column as per the manufacturer’s instructions. Flow 
through was collected. T cells were counted and resuspended in 107 cells/ml 
PBS with the addition of 1 nM CFSE and incubated at 37° for 10 min and 
then washed twice in complete RPMI medium with 5% FCS. 5 × 104 
CFSE-labeled T cells were plated per well with titrated ratios of m/chDC, 
spleen DC, and microglia populations after sort. At day 4, samples were 
stained with live/dead AQUA, Thy1.2, CD3, CD4, and CD8 antibodies and 
gated on CFSE divisions in CD3+Thy1.2+CD4/8+ subsets. To directly 
detect a self-antigen–MHC complex, we used Y-Ae mAb to identify com-
plexes of I-E peptide presented on I-Ab molecules in BALB/c × C57BL/6 
(CB1) mice, with BALB/c (I-E only) and C57BL/6 (I-Ab only) serving   
as controls.
For presentation of a myelin peptide to T cells, we used MOG 2D2 trans-
genic CD4+ T cells negatively enriched by MACS sorting from lymph nodes 
(mesenteric and skin draining) and spleens. 5 × 104 CFSE-labeled T cells per well 
were cultured with a maximum of 10 mg/ml MOG peptide (33–55) MEVGW-
YRSPFSR VVHLYRNGK at 99% purity (American Peptide Company). DC 
populations were co-cultured with T cells at a ratio of 1:10 DC/T cells.
Flow cytometry and sorting. Cells were stained on ice in PBS with 2.0% 
(vol/vol) FCS. LSR II (BD) was used for multiparameter flow cytometry 
of stained cell suspensions, followed by analysis with FlowJo software (Tree 
Star). Cells were gated as follows: microglia, Lin (CD19CD3NK1.1 
B220Ter119)  CD45intCD11c;  DCs,  LinCD45hiCD11c+;  polymor-
phonuclear leukocytes, CD3CD19NK1.1Ter119SSChiCD11bhiGr-1hi; 
monocytes,  SSCloCD11bhiCD115+;  CD8+  spleen  DCs,  Lin  (CD19CD3 
NK1.1B220Ter119) CD11c+CD8+; and CD8 spleen DCs, Lin (CD19 
CD3NK1.1B220Ter119)  CD11c+CD8.  Dead  cells  were  excluded 
with DAPI or AQUA staining.
educator at the gates during the onset of immune activity in 
the brain and help to explain the therapeutic effect of Flt3L 
inhibitor on reducing T cell infiltration in experimental auto-
immune encephalomyelitis (Skarica et al., 2009). In the fu-
ture, the targeted and specific ablation of m/chDCs in vivo 
will help to pinpoint their exact functions in brain meningeal 
immunity as well as cognitive process. The different ontogeny 
and function of m/chDCs and microglia have implications 
for immunotherapy of neurodegenerative and brain inflam-
matory diseases.
MATERIALS AND METHODS
Mice, parabiosis, and adoptive transfer. The CD11c-EYFP transgenic 
mouse was developed to identify DCs in vivo in the steady-state (Lindquist 
et al., 2004). Flt3/ mice were generated and provided by I. Lemischka 
(Mount Sinai Medical Center, New York, NY), MHC II-EGFP knockin 
mice (Boes et al., 2002) were obtained from Taconic, and 2D2 MOG trans-
genic  mice  were  obtained  from The  Jackson  Laboratory.  C57BL/6  and 
C57BL/6 Pep3b CD45.1+ (SJL) mice were purchased from The Jackson Lab-
oratory or were bred at the Rockefeller University.
Parabiotic mice were produced as described previously (Liu et al., 2007). 
Mice were anesthetized (2.5% [vol/vol] Avertin; Fluka) and shaved. Skin inci-
sions were made in the sides of two adjacent mice from hip to elbow, and   
ligaments were sutured together with chromic gut (Ethicon); then the skin 
incisions were closed with 9-mm stainless-steel wound clips. Mice were kept 
on antibiotics for the 3 wk after surgery. For adoptive transfer, 5 × 105 or the 
indicated number of sorted purified progenitors or precursors were trans-
ferred i.v. For some experiments, recipient mice were conditioned with lethal 
irradiation, 550 cGy plus 500 cGy with 3 h between irradiations, and cell 
suspensions were injected i.v. immediately after the second irradiation. Mice 
were on antibiotic-supplemented food (TestDiet). All mice were maintained 
in specific pathogen–free conditions, and protocols were approved by the 
Rockefeller University Animal Care and Use Committee.
Reagents. The following reagents were from purchased from BD or eBio-
science: anti-CD16-CD32 (2.4G2), biotin-conjugated anti–I-A/I-E (M5/ 
114.15.2),  anti–Y-Ae  (eBioY-Ae),  anti-CD45.2  (104),  fluorescein  iso-
thiocyanate–conjugated anti-CD45.2 (104), phycoerythrin-conjugated anti-
B220 (RA3-6B2), anti-CD40 (3/23), anti-CD62L (MEL-14), anti-CD24 
(M1/69), anti-CD36 (no. 72-1), anti-CD103 (2E7), anti-CD115 (AFS98), 
anti-Flt3 (A2F10), phycoerythrin-indodicarbocyanine–conjugated anti-CD45.1 
(A20),  phycoerythrin–carbocyanine  5.5–conjugated  anti–Gr-1(RB6-8C5), 
phycoerythrin-indotricarbocyanine–conjugated anti-CD3 (145-2C11), anti-
CD19  (1D3),  anti-NK1.1  (PK136),  anti-Ter119  (TER-119),  anti–Sca-1 
(D7),  anti-CD11b  (M1/70),  anti-CD11c  (N418),  anti–Gr-1  (RB6-8C5), 
anti-B220 (RA3-6B2), Pacific blue–conjugated anti-CD11b (M1/70), anti-
B220 (RA3-6B2), allophycocyanin-conjugated anti-CD11b (M1/70), anti-
CD11c (N418), anti-SIRP (P84), anti-CD205 (205yekta), anti-F4/80 
(BM8), anti–Dectin-1 (2A11; from AbD Serotec), anti–c-Kit (2B8), Alexa 
Fluor  700–conjugated  anti–I-A/I-E  (M5/114.15.2), Alexa  Fluor  750–
  conjugated anti-CD11b (M1/70), anti-CD11c (N418), BD Lyse lysing buf-
fer, Cytoperm/Cytofix solution, and Perm/Wash buffer. DAPI was purchased 
from Invitrogen. Antibiotin and anti-CD11c microbeads were obtained from 
Miltenyi Biotec. Other reagents used included PBS, FBS, and ACK lysing 
buffer (all Invitrogen).
Cell preparation. 6–8-wk-old C57BL/6 F mice were injected s.c. to the 
flank with 5 × 106 B16 murine Flt3L-secreting tumor cells. Between 12 and 
16 d at 8-mm tumor size, mice were sacrificed, and intracardiac perfusion 
was performed on Flt3L-treated and control mice using PBS with heparin   
(1 USP unit/ml) with observed blanching of the spleen. Brains with meninges 
and spleen were dissected. For some experiments, meninges were carefully 
removed with fine tweezers. Brain tissue was finely minced into confetti-sized 1704 DCs in the steady-state mouse brain | Anandasabapathy et al.
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Microarray. Microglia and brain DCs from brain, monocytes from bone 
marrow, and CD8+ and CD8 cDCs from spleen were purified by sorting 
from WT mice or mice injected with Flt3L-producing B16 melanoma cells. 
All cell samples were purified to >98% homogeneity. Total RNA extraction 
and DNA microarray analysis of gene expression were performed at the gene 
array facility (Memorial Sloan-Kettering Cancer Center, New York, NY). 
Fluorescent images of hybridized microarrays (MOE-430 2.0; Affymetrix) 
were obtained using a Genechip scanner (Affymetrix). Microarray data were 
analyzed using GeneSpring 10.0 software (Affymetrix). All samples were re-
peated at least three times with individually sorted cells and averaged. Micro-
array data are available in the National Center for Biotechnology Information 
GEO DataSets under accession no. GSE29949.
Two-photon microscopy. In some experiments, cardiac perfusion was per-
formed using PBS and 4% paraformaldehyde, and intact whole brains with 
meninges were embedded in low molecular weight agarose. Brains were cut 
into 4–5-mm coronal sections to access the ventricles for imaging of the 
choroid plexus. To image meninges, the brains were removed from the mouse 
and positioned up-right in a 30-mm Petri dish containing PBS and covered 
with a coverslip. To image the choroid plexus, brains coronally at the midcor-
tex were positioned in the Petri dish with the surgical margin facing upward 
and covered with a coverslip. Images of meninges and choroid plexus with 
surrounding parenchyma were obtained using a multiphoton laser-scanning 
microscope (Fluoview FV 1000MPE; Olympus) fitted with a Coherent Cha-
meleon  Vision II laser (tunable from 690–1,040 nm) and a 25×/NA 1.05 ob-
jective, controlled by FluoView (FV-10) software (Olympus) at the Rockefeller 
University Bio-Imaging Facility. To image EGFP and EYFP, the excitation 
wavelength was set between 910 and 930 nm; emission light was split by two 
dichroic mirrors at 510 and 560 nm into three channels, and band-pass filters 
optimized for detecting second harmonics (dichroic 510 nm, hq 460–510), 
EYFP (hq 495–540), and dsRed (hq 570–625) were used for detection.
In some experiments, blood vessels were directly labeled by cardiac perfu-
sion using a specially formulated aqueous solution containing 1,1-dioctadecyl-
3,3,3,3-tetramethylindocarbocyanine  perchlorate  (DiI;  Sigma-Aldrich)  as 
previously described (Li et al., 2008). In brief, mice were perfused sequentially 
with PBS, DiI, and 4% paraformaldehyde. To visualize the meninges and cho-
roid plexus in depth, tiled z stacks (300-mm deep and 10-µm z resolution) were 
acquired. Volocity (PerkinElmer) and Imaris (Bitplane) software were used for 
data representation. Photoshop (Adobe) was used for final processing.
Online supplemental material. Fig. S1 shows CD11c+MHC II+ cDCs 
in the spleen, bulk brain, and meninges. Fig. S2 shows CX3CR1 expres-
sion on m/chDCs. Fig. S3 shows that Flt3L treatment does not induce DC 
maturation. Fig. S4 shows the phenotype of m/chDCs. Fig. S5 shows that 
DC precursors populate meninges. Fig. S6 shows pre-DCs in the menin-
ges and their expansion induced by Flt3L. Video 1 shows the distribution 
of EGFP cells in the meninges and parenchyma in the brain of I-Ab mice. 
Online supplemental material is available at http://www.jem.org/cgi/ 
content/full/jem.20102657/DC1.
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